Healthleap, a South African-born healthtech startup founded in 2022 by siblings Jemima and Josiah Meyer, has raised $38 million in combined seed and Series A funding. The $8 million seed round was co-led by Sequoia Capital and First Round Capital, while Hummingbird Ventures led the $30 million Series A.
Originally focused on a nutrition tool for dietitians, Healthleap has since pivoted to build an AI-powered platform that detects conditions often missed in hospital patients—like malnutrition, delirium, aspiration pneumonia, pressure ulcers, and risk of readmission for congestive heart failure. The system mines both structured data—labs, vitals, weights—and clinicians’ free-text notes to flag early warning signs.
How It Works
The technology integrates directly with hospitals’ electronic health records. It employs language models to parse doctors’ notes for phrases such as recent weight loss, difficulty swallowing, and appetite changes—signals that often live in unstructured text. These clues are combined with structured metrics, then summarized each night. The next morning, care teams receive a risk score through their existing workflows, along with a dashboard detailing patient trends.
Healthleap is clear that it doesn’t make diagnoses. Instead, it surfaces patients who may benefit from closer clinical review.
Adoption, Impact & Business Model
In the last year, Healthleap has expanded from just a few hospitals to more than 50, including major systems like Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Over the same period, revenue has increased more than tenfold.
The company uses three-year contracts priced based on bed count, with pricing also tied to outcomes. Clients report a return on investment (ROI) of at least fivefold, and in some cases exceeding twentyfold annually. As an example, its malnutrition program at the Hospital of the University of Pennsylvania delivered an annualized financial impact of $23.8 million—$6.3 million in additional reimbursements and $17.5 million from shortened hospital stays.
Healthleap plans to invest this fresh capital into engineering, product development, sales, and customer success. Going forward, the startup aims to support detection for over 40 major health conditions and expand its platform’s reach into outpatient and home care settings.
This move reflects a growing industry focus on using AI to enhance clinical workflows without replacing clinicians. As hospitals grapple with large volumes of patients and limited attention, tools that extract insights from all parts of the medical record—especially unstructured notes—are increasingly valuable. What’s especially noteworthy is the ROI data: tangible financial impact can be a fast path to adoption in healthcare.
